Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigid M Wilson

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
Infection Control and Hospital Epidemiology|May 3, 2017
A Multicenter Randomized Trial to Determine the Effect of an Environmental Disinfection Intervention on the Incidence of Healthcare-Associated Clostridium difficile InfectionAmy J Ray, Abhishek Deshpande, Dennis Fertelli, et al.
Medrxiv : the Preprint Server for Health Sciences|May 10, 2023
Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccinationStefan Gravenstein, Frank DeVone, Oladayo A Oyebanji, et al.
JAMA Oncology|July 17, 2025
COVID-19 Vaccine Booster Uptake and Effectiveness Among US Adults With CancerJacek Skarbinski, Eric P Elkin, Yonah C Ziemba, et al.
Circulation Research|May 13, 2025
<i>Acinetobacter Baumannii</i> Secreted Protease CpaA Inhibits Factor XII-Mediated Bradykinin Generation and Neutrophil ActivationKris M Blair, Dillon J Bohinc, Kara L Bane, et al.
Open Forum Infectious Diseases|January 6, 2025
Feasibility of a Low-Intensity Intervention to Influence Antibiotic Prescribing Rates Use in Outpatient Settings: A Cluster Randomized Controlled Clinical TrialTaissa A Bej, Brigid M Wilson, Ukwen C Akpoji, et al.
Ebiomedicine|June 11, 2024
Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccinationStefan Gravenstein, Frank DeVone, Oladayo A Oyebanji, et al.
Journal of the American Geriatrics Society|August 17, 2023
Neutralization and binding antibody response to second bivalent COVID-19 vaccination in nursing home residentsOladayo A Oyebanji, Yasin Abul, Brigid M Wilson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2022
Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA VaccinationDavid H Canaday, Oladayo A Oyebanji, Debbie Keresztesy, et al.
Medrxiv : the Preprint Server for Health Sciences|December 15, 2021
Significantly elevated antibody levels and neutralization titers in nursing home residents after SARS-CoV-2 BNT162b2 mRNA booster vaccinationDavid H Canaday, Oladayo A Oyebanji, Elizabeth White, et al.
Ebiomedicine|May 23, 2022
COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residentsDavid H Canaday, Oladayo A Oyebanji, Elizabeth White, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
Infection Control and Hospital Epidemiology|May 3, 2017
A Multicenter Randomized Trial to Determine the Effect of an Environmental Disinfection Intervention on the Incidence of Healthcare-Associated Clostridium difficile InfectionAmy J Ray, Abhishek Deshpande, Dennis Fertelli, et al.
Medrxiv : the Preprint Server for Health Sciences|May 10, 2023
Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccinationStefan Gravenstein, Frank DeVone, Oladayo A Oyebanji, et al.
JAMA Oncology|July 17, 2025
COVID-19 Vaccine Booster Uptake and Effectiveness Among US Adults With CancerJacek Skarbinski, Eric P Elkin, Yonah C Ziemba, et al.
Circulation Research|May 13, 2025
<i>Acinetobacter Baumannii</i> Secreted Protease CpaA Inhibits Factor XII-Mediated Bradykinin Generation and Neutrophil ActivationKris M Blair, Dillon J Bohinc, Kara L Bane, et al.
Open Forum Infectious Diseases|January 6, 2025
Feasibility of a Low-Intensity Intervention to Influence Antibiotic Prescribing Rates Use in Outpatient Settings: A Cluster Randomized Controlled Clinical TrialTaissa A Bej, Brigid M Wilson, Ukwen C Akpoji, et al.
Ebiomedicine|June 11, 2024
Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccinationStefan Gravenstein, Frank DeVone, Oladayo A Oyebanji, et al.
Journal of the American Geriatrics Society|August 17, 2023
Neutralization and binding antibody response to second bivalent COVID-19 vaccination in nursing home residentsOladayo A Oyebanji, Yasin Abul, Brigid M Wilson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2022
Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA VaccinationDavid H Canaday, Oladayo A Oyebanji, Debbie Keresztesy, et al.
Medrxiv : the Preprint Server for Health Sciences|December 15, 2021
Significantly elevated antibody levels and neutralization titers in nursing home residents after SARS-CoV-2 BNT162b2 mRNA booster vaccinationDavid H Canaday, Oladayo A Oyebanji, Elizabeth White, et al.
Ebiomedicine|May 23, 2022
COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residentsDavid H Canaday, Oladayo A Oyebanji, Elizabeth White, et al.
Pageof 13